GILEAD SCIENCES, INC.【GILD】Income statement

Market cap

$150.3B

P/E ratio

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	7,949	8,385	9,703	11,202	24,890	32,639	30,390	26,107	22,127	22,449	24,689	27,305	27,281	27,116	28,754
Revenue growth (%)	-
Cost of revenue	1,870	2,124	2,471	2,859	3,788	4,006	4,261	4,371	4,853	4,675	4,572	6,601	5,657	6,498	6,251
Research & development	-	-	-	2,120	2,854	3,014	5,098	3,734	5,018	9,106	-	-	-	-	-
Selling, general & administrative	1,044	1,242	1,461	1,699	2,983	3,426	3,398	3,878	4,056	4,381	5,151	5,246	5,673	6,090	6,091
Operating margin (%)
Operating income	3,962	3,790	4,010	4,524	15,265	22,193	17,633	14,124	8,200	4,287	4,071	9,918	7,330	7,605	1,662
Operating expenses	3,987	4,596	5,692	6,678	9,625	10,446	12,757	11,983	13,927	18,162	20,618	17,387	19,951	19,511	27,092
Income before tax	3,914	3,651	3,612	4,208	14,856	21,659	17,097	13,529	7,799	5,160	1,669	8,278	5,814	6,859	690
Pretax margin (%)	49.2	43.5	37.2	37.6	59.7	66.4	56.3	51.8	35.2	23	6.8	30.3	21.3	25.3	2.4
Provision for income taxes	1,024	862	1,038	1,151	2,797	3,553	3,609	8,885	2,339	-204	1,580	2,077	1,248	1,247	211
Effective tax rate (%)
Net income	2,901	2,804	2,592	3,075	12,101	18,108	13,501	4,644	5,460	5,386	123	6,225	4,592	5,665	480
Net income margin (%)
Earnings per share	3.39	3.62	1.71	2.01	7.95	12.37	10.08	3.54	4.2	4.24	0.1	4.96	3.66	4.54	0.38
Diluted EPS	3.32	3.55	1.64	1.81	7.35	11.91	9.94	3.51	4.17	4.22	0.1	4.93	3.64	4.5	0.38
Dividend payout ratio (%)	-	-	-	-	-
Dividend per share	-	-	-	-	-	1.29	1.84	2.08	2.28	2.52	2.72	2.84	2.92	3	3.08